鲍曼不动杆菌
舒巴坦钠
克拉维酸
氨苄西林
微生物学
阿莫西林
体外
抗生素
不动杆菌
阿莫西林/克拉维酸
生物
医学
化学
细菌
亚胺培南
抗生素耐药性
生物化学
遗传学
铜绿假单胞菌
作者
Ashok Pandey,Arti Kapil,Seema Sood,Vikas Goel,Bimal Kumar Das,Pradeep Seth
标识
DOI:10.1128/jcm.36.11.3415-3416.1998
摘要
ABSTRACT In vitro susceptibility patterns of newer β-lactamase-inhibiting antibiotics ampicillin-sulbactam (A/S) and amoxicillin-clavulanic acid (A/C) for 100 consecutive isolates of Acinetobacter baumannii obtained from various clinical samples were studied. The A/C MIC for 86% of the strains was more than 16/8 μg/ml, whereas there was an A/S MIC of more than 16/8 μg/ml for only 38% of the strains. This showed that A/S has significantly superior in vitro activity compared to A/C against A. baumannii , although, theoretically, both should have similar activities. The therapeutic superiority of A/S over A/C needs to be studied, or else the breakpoints for these agents in in vitro tests need to be redefined.
科研通智能强力驱动
Strongly Powered by AbleSci AI